EPID-25 GERMLINE POLYMORPHISMS IN MGMT INCREASE ABILITY TO MODEL TEMOZOLOMIDE (TMZ)-RELATED MYELOTOXICITY RISK IN PATIENTS WITH GLIOBLASTOMA (GBM) TREATED ON NRG ONCOLOGY/RTOG 0825

Guardat en:
Dades bibliogràfiques
Publicat a:Neuro Oncol
Autors principals: Scheurer, Michael E., Zhou, Renke, Gilbert, Mark R., Bondy, Melissa L., Sulman, Erik P., Yuan, Ying, Liu, Yanhong, Vera-Bolanos, Elizabeth, Wendland, Merideth M., Brachman, David G., Stieber, Volker W., Komaki, Ritsuko R., Flickinger, John C., Kenyon, Lawrence C., Robins, H. Ian, Hunter, Grant K., Crocker, Ian R., Chao, Samuel T., Stella, Philip J., Pugh, Stephanie L., Armstrong, Terri
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2015
Matèries:
Abstracts from the 20th Annual Scientific Meeting of the Society for Neuro-Oncology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4638765/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nov213.25
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars